The researchers conducted animal studies tracking the effects of celecoxib on the growth of cancer cells from a tumour type known as
neurofibromatosis type II (NF2).
They are mostly sporadic but there are a few reports of ganglioneuromas associated with
neurofibromatosis type II and multiple endocrinologic neoplasia type II.
Auditory brainstem implantation improves speech recognition in
neurofibromatosis type II patients.
In the United States, the ABI is approved for use only in patients 12 years or older with
neurofibromatosis type II, an inherited disease that causes a non-malignant brain tumor on the hearing nerve, but it has shown limited effectiveness in adults.
The vestibular schwannomas on bilateral side is associated with
neurofibromatosis type II.
These findings suggested the presence of schwannomas and led to a presumptive diagnosis of
neurofibromatosis type II.
Donna Getz is a member of a family who has been dealing with the effects of
neurofibromatosis type II (NF2) for several generations.
This investigational device is designed to activate hearing neurons with more precision than previous devices to improve speech recognition for patients suffering from a hereditary disease called
Neurofibromatosis Type II (NF2).
Agenesis of internal carotid artery associated with
neurofibromatosis type II.
Like the ABI, the PABI is designed for patients suffering from
Neurofibromatosis Type II (NF2), a hereditary disease that can cause profound hearing loss through the growth of bilateral tumors on the vestibular nerves.
